Your browser is no longer supported. Please, upgrade your browser.
Settings
ATRI [NASD]
Atrion Corporation
Index- P/E37.45 EPS (ttm)17.44 Insider Own11.50% Shs Outstand1.83M Perf Week1.22%
Market Cap1.17B Forward P/E- EPS next Y- Insider Trans0.00% Shs Float1.43M Perf Month-1.39%
Income32.10M PEG- EPS next Q- Inst Own65.20% Short Float4.59% Perf Quarter-11.04%
Sales147.60M P/S7.92 EPS this Y-11.60% Inst Trans1.39% Short Ratio8.23 Perf Half Y-0.74%
Book/sh131.60 P/B4.96 EPS next Y- ROA12.20% Target Price- Perf Year-1.98%
Cash/sh23.35 P/C27.96 EPS next 5Y- ROE13.60% 52W Range567.00 - 745.00 Perf YTD1.68%
Dividend7.00 P/FCF224.78 EPS past 5Y2.40% ROI12.20% 52W High-12.75% Beta0.10
Dividend %1.07% Quick Ratio4.50 Sales past 5Y0.30% Gross Margin44.80% 52W Low14.64% ATR13.26
Employees636 Current Ratio8.20 Sales Q/Q-6.70% Oper. Margin24.20% RSI (14)49.71 Volatility1.39% 1.63%
OptionableNo Debt/Eq0.00 EPS Q/Q-6.90% Profit Margin21.80% Rel Volume0.22 Prev Close653.00
ShortableYes LT Debt/Eq0.00 Earnings- Payout37.70% Avg Volume7.97K Price650.00
Recom- SMA200.43% SMA50-0.31% SMA2001.06% Volume222 Change-0.46%
Apr-25-16Initiated BWS Financial Sell $300
Apr-12-21 01:31AM  
Mar-07-21 01:04AM  
Feb-27-21 01:45AM  
Feb-26-21 05:47PM  
02:50PM  
Jan-27-21 11:32PM  
Dec-28-20 11:43PM  
Dec-09-20 10:28PM  
Nov-25-20 11:53PM  
Nov-13-20 04:30PM  
Nov-09-20 04:30PM  
Oct-31-20 08:30AM  
Oct-05-20 06:53AM  
Sep-09-20 06:22AM  
Sep-06-20 10:09AM  
Aug-29-20 11:35PM  
Aug-20-20 04:30PM  
Aug-10-20 08:33AM  
Aug-06-20 04:30PM  
Jul-14-20 08:04AM  
Jul-05-20 05:06PM  
Jun-23-20 01:17PM  
Jun-07-20 01:08PM  
May-21-20 01:30PM  
06:48AM  
May-19-20 12:11PM  
May-07-20 04:30PM  
Apr-21-20 06:25AM  
Mar-26-20 10:22AM  
Mar-25-20 04:42PM  
Mar-08-20 05:14PM  
Feb-28-20 07:25AM  
Feb-26-20 04:30PM  
02:51PM  
Feb-19-20 12:21PM  
Feb-05-20 06:44AM  
Jan-28-20 11:41AM  
Jan-24-20 05:00AM  
Jan-10-20 05:54AM  
Dec-15-19 07:23AM  
Dec-11-19 12:17PM  
Nov-24-19 06:52AM  
Nov-12-19 11:48AM  
Nov-09-19 08:02AM  
Nov-01-19 04:30PM  
Oct-26-19 12:32PM  
Oct-14-19 06:37AM  
Sep-21-19 08:00AM  
Sep-13-19 01:54PM  
Aug-29-19 08:28AM  
Aug-19-19 04:30PM  
Aug-07-19 04:30PM  
Aug-06-19 03:09PM  
Jul-09-19 12:35PM  
Jun-12-19 02:14PM  
May-21-19 03:12PM  
May-17-19 03:48PM  
May-09-19 05:03AM  
May-08-19 04:30PM  
May-02-19 02:21PM  
Apr-19-19 09:43AM  
Mar-27-19 09:32AM  
Mar-20-19 03:59PM  
Mar-04-19 12:22PM  
Feb-26-19 04:30PM  
02:17PM  
Feb-21-19 08:00AM  
Feb-06-19 11:20AM  
Jan-11-19 10:47AM  
Dec-10-18 12:37PM  
Nov-12-18 01:22PM  
Nov-09-18 04:34PM  
04:30PM  
01:30PM  
Oct-19-18 08:20AM  
Oct-10-18 02:27PM  
Sep-04-18 02:16PM  
Aug-14-18 04:30PM  
Aug-07-18 05:00PM  
04:45PM  
May-31-18 07:10AM  
May-24-18 08:25AM  
May-22-18 03:05PM  
May-10-18 05:12AM  
May-09-18 04:30PM  
May-08-18 10:59AM  
Apr-03-18 08:00AM  
Mar-12-18 08:00AM  
Mar-10-18 09:14AM  
Feb-28-18 05:03AM  
Feb-27-18 04:30PM  
02:31PM  
Feb-21-18 11:58AM  
Feb-01-18 08:00AM  
Dec-18-17 02:38PM  
Dec-05-17 08:36AM  
Dec-01-17 10:26AM  
09:51AM  
Nov-27-17 07:32AM  
Nov-26-17 06:05AM  
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Germany, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, mixes critical drugs, controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BATTAT EMILE ADirector/Chairman of the BoardMar 12Option Exercise464.056,0002,784,300154,673Mar 16 11:58 AM
Battat David APresident & CEOMar 12Option Exercise538.006,0003,228,00043,715Mar 16 11:00 AM